SCHEDULE 13D/A
Beneficial Ownership Report
Camp4 Therapeutics Corp Filed Acc 0001193125-25-201410
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| Amir Nashat | 3,932,251 | 8.4% |
| Polaris Management Co. VII, L.L.C. | 3,023,161 | 6.4% |
| Polaris Partners VII, L.P. | 2,825,500 | 6.0% |
| Polaris Partners GP X, L.L.C. | 909,090 | 1.9% |
| Polaris Partners X, L.P. | 909,090 | 1.9% |
| Brian Chee | 909,090 | 1.9% |
| Amy Schulman | 909,090 | 1.9% |
| Polaris Entrepreneurs' Fund VII, L.P. | 197,661 | 0.4% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
- 2026-11-16 SCHEDULE 13G/A · Vivo Opportunity Fund Holdings, L.P. 9.99%
- 2026-11-13 SCHEDULE 13G/A · Coastlands Capital LP 9.99%
- 2026-11-12 SCHEDULE 13G · Adage Capital Management, L.P. 6.68%
- 2026-11-05 SCHEDULE 13G/A · FMR LLC 7.8%
- 2026-08-31 SCHEDULE 13D/A · Andrew J. Schwab 9.9%
- 2026-08-19 SCHEDULE 13D/A · Amir Nashat 6.3%
- 2026-08-14 SCHEDULE 13G/A · BALYASNY ASSET MANAGEMENT L.P. 4.99%
- 2026-08-10 SCHEDULE 13G · Trails Edge Capital Partners, LP 6%
- 2026-08-05 SCHEDULE 13D/A · Andrew J. Schwab 9.9%
- 2026-05-15 SCHEDULE 13G · Balyasny Asset Management L.P. 5.07%
- 2026-03-11 SCHEDULE 13D/A · Enavate Sciences GP, LLC 4.8%
- 2026-02-13 SCHEDULE 13G/A · Vivo Opportunity Fund Holdings, L.P. 7.4%
- 2026-02-05 SCHEDULE 13G/A · FMR LLC 9.5%
- 2026-01-08 SCHEDULE 13G · JANUS HENDERSON GROUP PLC 12.2%
- 2025-12-23 SCHEDULE 13D/A · Enavate Sciences GP, LLC 6.0%
- 2025-12-11 SCHEDULE 13G/A · Coastlands Capital LP 9.99%
- 2025-11-14 SCHEDULE 13G/A · Michael P. Rubin 4.8%
- 2025-11-14 SCHEDULE 13G/A · Marc L. Andreessen 4.5%
- 2025-11-07 SCHEDULE 13G/A · FMR LLC 6.7%
- 2025-10-07 SCHEDULE 13G · FMR LLC 15.0%
Loading xslSCHEDULE_13D_X01/primary_doc.xml…